PlainRecalls
FDA Devices Moderate Class II Terminated

Bartels Legionella Urinary Antigen- an adjunct to culture for the presumptive diagnosis of past or current Legionnaire's Disease by qualitative detection of Legionella Pneumophila seragroup 1 antigen in human urine. Product Code: B1029-440

Reported: December 22, 2021 Initiated: October 11, 2021 #Z-0382-2022

Product Description

Bartels Legionella Urinary Antigen- an adjunct to culture for the presumptive diagnosis of past or current Legionnaire's Disease by qualitative detection of Legionella Pneumophila seragroup 1 antigen in human urine. Product Code: B1029-440

Reason for Recall

Contamination of the conjugate may cause a pipetting issue which then could lead to an invalid assay

Details

Recalling Firm
Clark Laboratories, Inc.
Units Affected
53 units
Distribution
OH, UT
Location
Jamestown, NY

Frequently Asked Questions

What product was recalled?
Bartels Legionella Urinary Antigen- an adjunct to culture for the presumptive diagnosis of past or current Legionnaire's Disease by qualitative detection of Legionella Pneumophila seragroup 1 antigen in human urine. Product Code: B1029-440. Recalled by Clark Laboratories, Inc.. Units affected: 53 units.
Why was this product recalled?
Contamination of the conjugate may cause a pipetting issue which then could lead to an invalid assay
Which agency issued this recall?
This recall was issued by the FDA Devices on December 22, 2021. Severity: Moderate. Recall number: Z-0382-2022.